000			01706 a2200481 4500
005			20250514003038.0
264		0	_c20011101
008			200111s 0 0 eng d
022			_a0171-6425
024	7		_a10.1055/s-2001-14293 _2doi
040			_aNLM _beng _cNLM
100	1		_aKamler, M
245	0	0	_aHirudin protects from leukocyte/endothelial cell interaction induced by extracorporeal circulation. _h[electronic resource]
260			_bThe Thoracic and cardiovascular surgeon _cJun 2001
300			_a157-61 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntithrombins _xpharmacology
650	0	4	_aArterioles _xdrug effects
650	0	4	_aCell Adhesion _xdrug effects
650	0	4	_aCell Communication _xdrug effects
650	0	4	_aCircadian Rhythm _xdrug effects
650	0	4	_aCricetinae
650	0	4	_aDisease Models, Animal
650	0	4	_aElectrocardiography
650	0	4	_aEndothelium, Vascular _xcytology
650	0	4	_aExtracorporeal Circulation _xadverse effects
650	0	4	_aHemodynamics _xdrug effects
650	0	4	_aHirudins _xpharmacology
650	0	4	_aLeukocytes _xdrug effects
650	0	4	_aMesocricetus
650	0	4	_aMicrocirculation _xdrug effects
650	0	4	_aMuscle, Smooth, Vascular _xblood supply
650	0	4	_aTime Factors
650	0	4	_aVenules _xdrug effects
700	1		_aChatterjee, T
700	1		_aStemberger, A
700	1		_aGebhard, M M
700	1		_aHagl, S
700	1		_aJakob, H
773	0		_tThe Thoracic and cardiovascular surgeon _gvol. 49 _gno. 3 _gp. 157-61
856	4	0	_uhttps://doi.org/10.1055/s-2001-14293 _zAvailable from publisher's website
999			_c11361705 _d11361705